Qiu‐jiang Yan

Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction

Siyu Zeng, Li Yang, Qiu‐jiang Yan et al. · Biomedicine & Pharmacotherapy · 2018 · 32 citations · Full text

Hypertension, Immunology, Cardiovascular Pharmacology +21

Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway

Siyu Zeng, Li Yang, Huiqin Lu et al. · Journal of Cellular and Molecular Medicine · 2019 · 31 citations · Full text

Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells

Siyu Zeng, Li Yang, Chenliang Hong et al. · Mediators of Inflammation · 2018 · 13 citations · Full text

Protective Action, Immunology, Adam17 Sirna +21

A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-<i>α</i> Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy

Siyu Zeng, Huiqin Lu, Qiu‐jiang Yan et al. · PPAR Research · 2018 · 12 citations · Full text

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2

Siyu Zeng, Qiu‐jiang Yan, Li Yang et al. · Mediators of Inflammation · 2020 · 11 citations · Full text